Loading...
CVRx, Inc.
CVRX•NASDAQ
Healthcare
Medical - Devices
$8.34
$0.15(1.83%)
CVRx, Inc. (CVRX) Financial Performance & Income Statement Overview
Review CVRx, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
30.53%
↑ 30.53%
Operating Income Growth
-38.02%
↓ 38.02%
Net Income Growth
-45.55%
↓ 45.55%
Operating Cash Flow Growth
-0.32%
↓ 0.32%
Operating Margin
-95.89%
↓ 95.89%
Gross Margin
83.69%
↑ 83.69%
Net Profit Margin
-97.49%
↓ 97.49%
ROE
-79.04%
↓ 79.04%
ROIC
-41.87%
↓ 41.87%
CVRx, Inc. (CVRX) Income Statement & Financial Overview
Review CVRx, Inc.'s (CVRX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $15.34M | $13.37M | $11.81M | $10.77M |
| Cost of Revenue | $2.30M | $2.25M | $2.04M | $1.75M |
| Gross Profit | $13.04M | $11.13M | $9.77M | $9.02M |
| Gross Profit Ratio | $0.85 | $0.83 | $0.83 | $0.84 |
| R&D Expenses | $2.81M | $2.50M | $2.77M | $3.06M |
| SG&A Expenses | $20.51M | $21.63M | $20.97M | $28.20M |
| Operating Expenses | $23.32M | $24.14M | $23.74M | $31.26M |
| Total Costs & Expenses | $25.62M | $26.38M | $25.78M | $33.002M |
| Interest Income | -$960000.00 | $0.00 | $0.00 | $960000.00 |
| Interest Expense | $1.52M | $958000.00 | $959000.00 | $960000.00 |
| Depreciation & Amortization | $178000.00 | $169000.00 | $141000.00 | $131000.00 |
| EBITDA | -$13.62M | -$11.93M | -$12.89M | -$21.06M |
| EBITDA Ratio | -$0.89 | -$0.89 | -$1.09 | -$1.96 |
| Operating Income | -$10.27M | -$13.01M | -$13.97M | -$22.23M |
| Operating Income Ratio | -$0.67 | -$0.97 | -$1.18 | -$2.06 |
| Other Income/Expenses (Net) | -$448000.00 | -$41000.00 | -$15000.00 | $84000.00 |
| Income Before Tax | -$10.72M | -$13.05M | -$13.99M | -$22.15M |
| Income Before Tax Ratio | -$0.70 | -$0.98 | -$1.18 | -$2.06 |
| Income Tax Expense | -$71000.00 | $47000.00 | $41000.00 | $38000.00 |
| Net Income | -$10.65M | -$13.10M | -$14.03M | -$22.19M |
| Net Income Ratio | -$0.69 | -$0.98 | -$1.19 | -$2.06 |
| EPS | -$0.39 | -$0.57 | -$0.65 | -$1.04 |
| Diluted EPS | -$0.39 | -$0.57 | -$0.65 | -$1.04 |
| Weighted Avg Shares Outstanding | $22.60M | $22.78M | $21.63M | $21.23M |
| Weighted Avg Shares Outstanding (Diluted) | $22.60M | $22.78M | $21.63M | $21.23M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan